In the cancer type multiple myeloma, the malignant cells differ significantly from normal cells regarding the layer of ...

Researchers from Mass General Brigham and the Broad Institute of MIT and Harvard have identified genetic modifications that ...

Learning about early symptoms may help you in the long run. Here are the early symptoms to know, according to medical ...

MMRF continues to drive the critical global research collaborations that lead to scientific breakthroughs and improved patient outcomesNORWALK, Conn., Sept. 20, 2025 (GLOBE NEWSWIRE) -- Today, the ...

Researchers at Duke University have shown that blocking an enzyme involved in iron regulation not only kills multiple myeloma cancer ...

Researchers from Mass General Brigham and the Broad Institute of MIT and Harvard have identified genetic modifications that can improve the efficacy ...

Among 78 patients with relapsed or refractory disease, the 24-month relapse-free rate after treatment discontinuation was 68% ...

Earlier this month, the FDA approved Bildyos and Bilprevda (denosumab-nxxp), 2 additional denosumab biosimilars for Prolia ...